The University of Chicago is one of the leading academic institutions in the United States, and the Section of Urology shares in this heritage as a result of the work of Dr. Charles Huggins, who was awarded the Nobel Prize in Medicine in 1966 for his discovery of hormone therapy for the treatment of advanced prostate cancer. The section continues this commitment to excellence in clinical practice and basic research. The goals of our residency program are to provide excellent comprehensive clinical training in all aspects of urology and to create an atmosphere for discovery by providing active research. Thus, we endeavor to provide our residents with the best training in clinical urology while enabling them to advance the science of urology through investigation.

To achieve these goals, the full and part time faculty are committed to developing an organized program of diverse clinical activities, a rigorous and comprehensive conference schedule, guidance and support in clinical and laboratory research activities, and supervision commensurate with the resident’s level of ability in clinical patient care.

Residency Research

The Section of Urology is a traditional academic training program, sustaining the legacy of Dr. Charles Huggins, our former section chief who was awarded the Nobel Prize in Medicine in 1966 for the discovery of hormonal therapy to treat advanced prostate cancer. We have an extensive research program that integrates basic laboratory, translational and clinical investigation in cancer, urolithiasis, reconstruction and minimally invasive technologies.

Residents at all levels of training are encouraged to pursue clinical research projects and write chapters and review articles. With the assistance and guidance of our faculty, residents are taught to design and implement hypothesis-driven clinical studies and to then critically assess and report the results.

Dedicated Research Year (PGY-4):

The PGY-4 year is devoted entirely to investigation in a mentored research environment. The primary objective of the PGY-4 year is to have residents identify a fundamental question in urology and to initiate, design and complete a research project to answer that question.

During the latter half of the PGY-3 year, residents are expected to choose a research mentor from within the section. Residents may choose to work in one of the following areas:

  • Prostate stem cell research (Dr. Donald VanderGriend)
  • Basic cancer research (Dr. Carrie Rinker-Schaeffer)
  • Prostate cancer metastatic colonization research (Dr. Russell Szmulewitz)
  • Minimally invasive laboratory research (Dr. Arieh Shalhav)
  • Nephrolithiasis laboratory research (Dr. Glenn Gerber)
  • Bladder cancer research (Dr. Gary Steinberg)
  • Bladder physiology research (Dr. Gregory Bales)
  • Renal cell cancer research (Dr. Scott Eggener)

All of these investigators have established strong collaborations and relationships with other basic and clinical investigators throughout The University of Chicago, which enables the PGY-4 residents to interact with other scientists in both formal and informal research settings. Their research mentors will guide them through the development of a hypothesis and the design of an experimental protocol to test that hypothesis.

In general, the PGY-4 residents are expected to conduct scientific research in the same manner as basic science graduate students and post-doctoral fellows. This enables them to develop a genuine understanding of scientific methodology and the execution of independent research.